SCYNEXIS Stock

SCYNEXIS Book Value per Share

The Book Value per Share of SCYNEXIS (SCYX) as of Sep 4, 2026 is 1.31 USD. In the previous year, Book Value per Share was 1.74 USD — a change of -24.51% (lower).

Book Value per Share

1.31USD

YoY

-24.51%

Last updated:

Book Value per Share of SCYNEXIS is 2026 1.31 USD. Book Value per Share of SCYNEXIS was 2025 1.74 USD. It decreases by -24.51% lower compared to the previous year.

The SCYNEXIS Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2017
0.51 USD
Jan 1, 2018
0.74 USD
Jan 1, 2019
0.31 USD
Jan 1, 2020
0.54 USD
Jan 1, 2021
0.98 USD
Jan 1, 2022
0.08 USD
Jan 1, 2023
1.74 USD
Jan 1, 2024
1.31 USD
The SCYNEXIS Book Value per Share history
YEARBook Value per ShareYoY
1.31USD-24.51%
1.74USD+2,180.06%
0.08USD-92.25%
0.98USD+81.14%
0.54USD+76.74%
0.31USD-58.65%
0.74USD+45.79%
0.51USD-38.51%
0.83USD-16.95%
1.00USD+25.45%
0.80USD—
Access this data via the Eulerpool API
Get Free API Key

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Book Value per Share of SCYNEXIS is 1.31 USD in 2026.

Book Value per Share of SCYNEXIS changed from 1.74 USD to 1.31 USD, representing a -24.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — SCYNEXIS

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — SCYNEXIS